Чили - испански - ISPC (Instituto de Salud Pública de Chile)

cosmÉticos avon s.a. - sin formulas

Чили - испански - ISPC (Instituto de Salud Pública de Chile)

l'oreal chile s.a. - sin formulas

Чили - испански - ISPC (Instituto de Salud Pública de Chile)

promotora de belleza s.a. - sin formulas

Чили - испански - ISPC (Instituto de Salud Pública de Chile)

comercial pichara spa - sin formulas

Европейски съюз - испански - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinuria, paroxística - inmunosupresores - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.

Чили - испански - ISPC (Instituto de Salud Pública de Chile)

mini bf chile spa - sin formulas

Европейски съюз - испански - EMA (European Medicines Agency)

horizon therapeutics ireland dac - inebilizumab - neuromyelitis optica - inmunosupresores - uplizna is indicated as monotherapy for the treatment of adult patients with neuromyelitis optica spectrum disorders (nmosd) who are anti-aquaporin 4 immunoglobulin g (aqp4-igg) seropositive (see section 5.

Европейски съюз - испански - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - carcinoma, pulmón no microcítico - agentes antineoplásicos - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Европейски съюз - испански - EMA (European Medicines Agency)

theramex ireland limited - abaloparatide - osteoporosis, postmenopausal; osteoporosis - homeostasis del calcio - tratamiento de la osteoporosis en mujeres posmenopáusicas con mayor riesgo de fractura.

Европейски съюз - испански - EMA (European Medicines Agency)

hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vacunas - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.